NCT00657020View on ClinicalTrials.gov

Functional Magnetic Resonance Imaging (fMRI) Investigation of Nicotine Withdrawal Symptoms

PHASE4CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Smoking

Interventions

DRUG

Nicotine

Nicotine lozenge containing 4 mg of nicotine

DRUG

Placebo

Placebo lozenge

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY